Abstract
Purpose
Patients with end-stage renal disease (ESRD) have an increased risk of developing renal cell carcinoma (RCC). This retrospective study compared clinical and pathological outcomes of RCC occurring in native kidneys of patients with ESRD (whether they underwent kidney transplantation or not) with those of renal tumors diagnosed in the general population.
Methods
The study included a total of 533 patients with RCC. The ESRD cohort included 92 patients with RCC in native kidneys. Of these, 58 and 34 cases were identified before (pre-Tx group) and after kidney transplantation (post-Tx group), respectively. The control group was composed of 441 RCCs diagnosed in the general population. Variables were compared by chi-square and Student’s t tests. Cancer-specific survival was assessed by Kaplan–Meier and Cox methods.
Results
The ESRD groups had smaller (P = 0.001), lower-grade, and lower-stage tumors than the non-ESRD group (P = 0.001). The papillary RCC rate was higher in the ESRD groups (P = 0.01). Ten-year cancer-specific survivals were 94.5, 87.9, and 74.6 % in pre-Tx, post-Tx, and non-ESRD patients, respectively (P = 0.003). Mean follow-up was 90.2 months. At multivariate analysis, tumor size (HR = 1.10), pathological stage (HR = 1.46), presence of nodal (HR = 2.22) and visceral metastases (HR = 3.49), and Fuhrman grade (HR = 1.48) were independent adverse prognostic factors for cancer-specific survival.
Conclusions
Native kidney RCCs arising in ESRD patients are lower stage and lower grade as compared to RCCs diagnosed in the general population, and these tumors exhibit favorable clinical and outcome features.
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30
Lee JE, Han SH, Cho BC et al (2009) Cancer in patients on chronic dialysis. J Korean Med Sci 24(Suppl. 1):S95–S101
Russo P (2012) End stage and chronic kidney disease: associations with renal cancer. Front Oncol 2:28. doi:10.3389/fonc.2012.00028
Barama A, St-Louis G, Nicolet V et al (2005) Renal cell carcinoma in kidney allografts: a case series from a single center. Am J Transpl 5(12):3015–3018
Chambade D, Meria P, Tariel E et al (2008) Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center. J Urol 180(5):2106–2109
Leveridge M, Musquera M, Evans A et al (2011) Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients. J Urol 186(1):219–223
Bijol V, Mendez GP, Hurwitz S et al (2006) Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol 30:575–584
Henriksen KJ, Meehan SM, Chang A (2009) Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated. Arch Pathol Lab Med 133:1012–1025
Stengel B (2010) Chronic kidney disease and cancer: a troubling connection. J Nephrol 23:253–262
Birkelan SA, Lokkegaard H, Storm HH (2000) Cancer risk in patients on dialysis and after renal transplantation. Lancet 355:1886–1887
Buell JF, Gross TG, Woodle ES (2005) Malignancy after transplantation. Transplantation 80:S254–S264
Mandayam S, Shahinian VB (2008) Are chronic dialysis patients at increased risk for cancer? J Nephrol 21:166–174
Piselli P, Serraino D, Segoloni GP et al (2013) Risk of de novo cancers after transplantation: results from a cohort of 7,217 kidney transplant recipients, Italy 1997–2009. Eur J Cancer 49(2):336–344
Tickoo SK, dePeralta-Venturina MN, Harik LR et al (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30(2):141–153
Gobbo S, Eble JN, Grignon DJ et al (2008) Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 32(8):1239–1245
Neuzillett Y, Tillou X, Mathieu R et al (2011) Renal cell carcinoma (RCC) in patients with end stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol 60:366–373
Gigante M, Neuzillet Y, Patard JJ et al (2012) Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities? BJU Int 110(11 Pt B):E570–E573
Ishikawa I, Saito Y, Asaka M et al (2003) Twenty-year follow-up of acquired renal cystic disease. Clin Nephrol 59(3):153–159
Ishikawa I, Hayama S, Morita K et al (2010) Long-term natural history of acquired cystic disease of the kidney. Ther Apher Dial 1 14(4):409–416
Hughson MD, Buchwald D, Fox M (1986) Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med 110(7):592–601
Cheuk W, Lo ES, Chan AK, Chan JK (2002) Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations. Hum Pathol 33(7):761–765
Hori Y, Oda Y, Kiyoshima K et al (2007) Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis. J Pathol 212(2):218–226
Konda R, Sato H, Hatafuku F et al (2004) Expression of hepatocyte growth factor and its receptor C-met in acquired renal cystic disease associated with renal cell carcinoma. J Urol 171(6 Pt 1):2166–2170
Kuroda N, Shiotsu T, Hes O et al (2010) Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. Med Mol Morphol 43(4):231–234
Ikeda R, Tanaka T, Moriyama MT et al (2002) Proliferative activity of renal cell carcinoma associated with acquired cystic disease of the kidney: comparison with typical renal cell carcinoma. Hum Pathol 33(2):230–235
Ianhez LE, Lucon M, Nahas WC et al (2007) Renal cell carcinoma in renal transplant patients. Urology 69:462–464
Moudouni SM, Lakmichi A, Tligui M et al (2006) Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int 98:298–302
Rohan SM, Xiao Y, Liang Y et al (2011) Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 24(9):1207–1220
Fisher KE, Yin-Goen Q, Alexis D et al (2013) Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Mod Pathol. doi:10.1038/modpathol.2013.140. (Epub ahead of print)
Navarro MD, López-Andréu M, Rodríguez-Benot A et al (2008) Cancer incidence and survival in kidney transplant patients. Transpl Proc 40(9):2936–2940
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Breda Alberto and Lucarelli Giuseppe have contributed equally to this study.
Ditonno Pasquale and Villavicencio Humberto share senior authorship.
Rights and permissions
About this article
Cite this article
Breda, A., Luccarelli, G., Rodriguez-Faba, O. et al. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. World J Urol 33, 1–7 (2015). https://doi.org/10.1007/s00345-014-1248-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-014-1248-y